News
-
Ten Years implementing Personalised Medicine – joint ICPerMed and EP PerMed Conference in Prague
The European Partnership for Personalised Medicine (EP PerMed) and the International Consortium for Personalised Medicine (ICPerMed) jointly organised a conference on the achievements in personalised medicine in the last decade on 26 and 27 November 2025 in Prague, Czech Republic. The conference brought together around 150 international experts and stakeholders in the field to celebrate the tenth anniversary…
-
EP PerMed Extended General Assembly Meeting in Prague
The EP PerMed Extended General Assembly (ExtGeA), consisting of the EP PerMed partners and ICPerMed members, met in Prague on 25 November 2025 to discuss synergies, cooperation opportunities and the work programmes of the two initiatives.
-
Call Announcement: JTC2026 – Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
The Joint Transnational Call (JTC) 2026 “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union, will fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field. The available budget for this…
-
Pre-Announcement: Fast Track 2026
EP PerMed will launch the Fast Track Programme 2026 on 2 December 2025, offering targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.
EP PerMed JTC2026
Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
EP PerMed will fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. The available budget for this call is 38 Mio. € (approx.). Deadline for pre-proposal submission in 10 February 2026.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.